Zephyrious acquires Opus Automation accelerating new controlled released product development

Ottawa, Jul 12, 2019 (Issuewire.com) – Zephyrious acquires manufacturing automation leader Opus Automation accelerating new controlled release product development.

Manufacturing and packaging automation leader Opus (www.opusautomation.com) has been acquired by Zephyrious. Building on decades of success within the automotive and packaging industries, Zephyrious has acquired the technology to enable each of its partners to:

More on StockNewDesk:

  • scale production of new products to geographic and consumer demand and profitability
  • provide innovative packaging and cost-effective shipping
  • comply with regulatory and product tracking requirements

Combining these capabilities with Zephyrious’ formulation expertise in controlled release products enables its health care and consumer products clients to:

  • cut costs and improve the reliability of clinical trials
  • reduce manufacturing development costs and shorten timelines for scale up production to market demand
  • track products from production to consumption and prevent product counterfeiting

About Opus Automation
Established in 1998, Opus Automation is an engineering manufacturing based company specializing in robotic solutions, and automated solutions, for the North American market. Opus provides “best in class” automation solutions to its customers’ unique requirements. Its innovative and intelligent design solutions simultaneously increase their profitability. Contact Mr Young at [email protected]

About Zephyrious
Zephyrious is a team of industry-tested experts with decades of experience in the development and manufacturing of innovative medical products. The Zephyrious team brings expertise in pharmacology, regulatory affairs, efficient clinical testing strategies, chemistry and product development to enable its licensed producer clients to rapidly develop and launch best in class controlled delivery products. For more information www.zephyrious.co or [email protected]

Source :zephyrious health innovation

This article was originally published by IssueWire. Read the original article here.

Latest on StockNewDesk:

Login

Lost your password?